HebeCell Corp is a wholly owned subsidiary of Vcanbio USA. Established in April 2016, the company is located at Vcanbio USA facility in Natick MA and its laboratories are equipped with state-of-art instruments for both R&D and process development of cell-based therapeutic products. Our scientific leadership team consists of pioneers and veterans of the stem cell field with successful track record in both the translation and commercialization of novel stem cell therapies.
Within the Vcanbio global organization, HebeCell is striving to be the leading internal R&D entity for innovation and future technology development. One of our major strength is that we have been able to build mutually beneficial relationships with top scientists and entrepreneurs in the Boston biotech community. We are open for collaboration and co-development with both academic and industrial organizations who share the same vision and drive in exploring the true potential of stem cells and regenerative medicine in not too long future.